|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2005-11-10
|
|
pubmed:abstractText |
The efficacy of combination therapy with pegylated interferon (PEG IFN) alpha plus ribavirin (RBV) in the retreatment of chronic hepatitis C (CHC) in patients who previously failed combination standard IFN plus RBV or IFN monotherapy has not been well established.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Carriers,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-alpha,
http://linkedlifedata.com/resource/pubmed/chemical/Polyethylene Glycols,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Viral,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Ribavirin,
http://linkedlifedata.com/resource/pubmed/chemical/interferon alfa-2b,
http://linkedlifedata.com/resource/pubmed/chemical/peginterferon alfa-2b
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0002-9270
|
|
pubmed:author |
pubmed-author:AhmedFurqaanF,
pubmed-author:AytamanAyseA,
pubmed-author:BermanDavid HDH,
pubmed-author:BiniEdmund JEJ,
pubmed-author:BodenheimerHenry CHCJr,
pubmed-author:BräuNorbertN,
pubmed-author:BrodskyNeilN,
pubmed-author:BrownRobert SRSJr,
pubmed-author:CerulliMaurice AMA,
pubmed-author:ChaitMaxwellM,
pubmed-author:EdlinBrian RBR,
pubmed-author:EhrlichJamesJ,
pubmed-author:EspositoStephen PSP,
pubmed-author:GardnerPeter WPW,
pubmed-author:GedersJane MJM,
pubmed-author:GonzalezStevan ASA,
pubmed-author:JacobsonIra MIM,
pubmed-author:KlionFranklin MFM,
pubmed-author:LebovicsEdwardE,
pubmed-author:MinAlbert DAD,
pubmed-author:RahminMichael GMG,
pubmed-author:RovnerDeborahD,
pubmed-author:RussoMark WMW,
pubmed-author:SpivackJulie EJE,
pubmed-author:TobiasHillelH
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
100
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2453-62
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:16279900-African Americans,
pubmed-meshheading:16279900-Antiviral Agents,
pubmed-meshheading:16279900-Drug Carriers,
pubmed-meshheading:16279900-Drug Combinations,
pubmed-meshheading:16279900-European Continental Ancestry Group,
pubmed-meshheading:16279900-Female,
pubmed-meshheading:16279900-Follow-Up Studies,
pubmed-meshheading:16279900-Genotype,
pubmed-meshheading:16279900-Hepacivirus,
pubmed-meshheading:16279900-Hepatitis C, Chronic,
pubmed-meshheading:16279900-Humans,
pubmed-meshheading:16279900-Interferon-alpha,
pubmed-meshheading:16279900-Male,
pubmed-meshheading:16279900-Middle Aged,
pubmed-meshheading:16279900-Polyethylene Glycols,
pubmed-meshheading:16279900-RNA, Viral,
pubmed-meshheading:16279900-Recombinant Proteins,
pubmed-meshheading:16279900-Recurrence,
pubmed-meshheading:16279900-Retreatment,
pubmed-meshheading:16279900-Ribavirin,
pubmed-meshheading:16279900-Treatment Outcome,
pubmed-meshheading:16279900-Viral Load
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
A randomized trial of pegylated interferon alpha-2b plus ribavirin in the retreatment of chronic hepatitis C.
|
|
pubmed:affiliation |
Center for the Study of Hepatitis C and Division of Gastroenterology and Hepatology, Weill Medical College of Cornell University, New York, New York 10021, USA.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial
|
